Rnc Capital Management LLC Pfizer Inc Transaction History

Rnc Capital Management LLC

$1.73 Billion
Q4 2024

A detailed history of Rnc Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rnc Capital Management LLC holds 13,453 shares of PFE stock, worth $359,598. This represents 0.02% of its overall portfolio holdings.

Number of Shares

13,453

Previous 54,113 75.14%

Holding current value

$359,598

Previous $1.57 Million 77.27%

% of portfolio

0.02%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 27, 2025	SELL	$24.8 - $30.19 $1.01 Million - $1.23 Million	-40,660 Reduced 75.14%	13,453 $356,000
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $80,680 - $94,542	3,194 Added 6.27%	54,113 $1.51 Million
Q1 2024 Aug 07, 2024	BUY	$25.89 - $29.73 $358,265 - $411,403	13,838 Added 37.32%	50,919 $1.41 Million
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $700,310 - $909,625	-26,801 Reduced 41.95%	37,081 $1.07 Million
Q3 2023 Dec 27, 2023	SELL	$32.09 - $37.51 $958,817 - $1.12 Million	-29,879 Reduced 31.87%	63,882 $2.12 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $482,527 - $558,272	13,359 Added 16.62%	93,761 $3.44 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $44,313 - $57,690	-1,125 Reduced 1.38%	80,402 $3.28 Million
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $323,186 - $421,884	-7,741 Reduced 8.67%	81,527 $4.18 Million
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $97,103 - $118,538	-2,219 Reduced 2.43%	89,268 $3.91 Million
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $485,028 - $575,092	10,424 Added 12.86%	91,487 $4.8 Million
Q1 2022 Jul 22, 2022	BUY	$45.75 - $56.69 $1.19 Million - $1.47 Million	25,987 Added 47.18%	81,063 $4.2 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $79,954 - $118,518	1,935 Added 3.64%	55,076 $3.25 Million
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $5,259 - $6,756	134 Added 0.25%	53,141 $2.29 Million
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $66,182 - $74,973	-1,843 Reduced 3.36%	53,007 $2.08 Million
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $438,886 - $494,975	-13,105 Reduced 19.28%	54,850 $1.99 Million
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $183,582 - $233,441	5,485 Added 8.78%	67,955 $2.5 Million
Q3 2020 Dec 03, 2020	BUY	$31.75 - $37.25 $33,750 - $39,596	1,063 Added 1.73%	62,470 $2.29 Million
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $126,624 - $153,614	4,204 Added 7.35%	61,407 $2.01 Million
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $30,814 - $44,026	-1,140 Reduced 1.95%	57,203 $1.87 Million
Q4 2019 Mar 09, 2020	BUY	$32.92 - $37.36 $146,395 - $166,139	4,447 Added 8.25%	58,343 $2.29 Million
Q3 2019 Jul 22, 2020	SELL	$32.49 - $42.13 $325,939 - $422,648	-10,032 Reduced 15.69%	53,896 $1.94 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $197,842 - $222,132	5,350 Added 9.13%	63,928 $2.77 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $98,812 - $108,562	-2,635 Reduced 4.3%	58,578 $2.49 Million
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $207,545 - $236,624	-5,395 Reduced 8.1%	61,213 $2.67 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $316,572 - $383,983	-9,184 Reduced 12.12%	66,608 $2.94 Million
Q2 2018 Jul 20, 2018	SELL	$32.98 - $35.16 $32 Million - $34.1 Million	-969,395 Reduced 92.75%	75,792 $2.75 Million
Q1 2018 Apr 11, 2018	SELL	$31.91 - $37.02 $1.41 Million - $1.63 Million	-44,040 Reduced 4.04%	1,045,187 $37.1 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $250,115 - $265,380	7,520 Added 0.7%	1,089,227 $39.5 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $22,661 - $24,963	731 Added 0.07%	1,081,707 $38.6 Million
Q2 2017 Aug 22, 2017	BUY	N/A	1,080,976	1,080,976 $36.3 Million

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.

Account

Rnc Capital Management LLC Pfizer Inc Transaction History